img

Global Injection Influenza Vaccine Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Injection Influenza Vaccine Market Research Report 2024

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
According to Mr Accuracy reports new survey, global Injection Influenza Vaccine market is projected to reach US$ 10970 million in 2029, increasing from US$ 7635 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Injection Influenza Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Injection Influenza Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Segment by Application


6 Months to 3 Years
> 3 Years

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Injection Influenza Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Injection Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Injection Influenza Vaccine
1.2 Injection Influenza Vaccine Segment by Type
1.2.1 Global Injection Influenza Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Injection Influenza Vaccine Segment by Application
1.3.1 Global Injection Influenza Vaccine Market Value by Application: (2024-2034)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Injection Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Injection Influenza Vaccine Revenue 2018-2029
1.4.2 Global Injection Influenza Vaccine Sales 2018-2029
1.4.3 Global Injection Influenza Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Injection Influenza Vaccine Market Competition by Manufacturers
2.1 Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Injection Influenza Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Injection Influenza Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Injection Influenza Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injection Influenza Vaccine, Product Type & Application
2.7 Injection Influenza Vaccine Market Competitive Situation and Trends
2.7.1 Injection Influenza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injection Influenza Vaccine Players Market Share by Revenue
2.7.3 Global Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injection Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Injection Influenza Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Injection Influenza Vaccine Global Injection Influenza Vaccine Sales by Region: 2018-2029
3.2.1 Global Injection Influenza Vaccine Sales by Region: 2018-2024
3.2.2 Global Injection Influenza Vaccine Sales by Region: 2024-2029
3.3 Global Injection Influenza Vaccine Global Injection Influenza Vaccine Revenue by Region: 2018-2029
3.3.1 Global Injection Influenza Vaccine Revenue by Region: 2018-2024
3.3.2 Global Injection Influenza Vaccine Revenue by Region: 2024-2029
3.4 North America Injection Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Injection Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Injection Influenza Vaccine Sales by Country (2018-2029)
3.4.3 North America Injection Influenza Vaccine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injection Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Injection Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Injection Influenza Vaccine Sales by Country (2018-2029)
3.5.3 Europe Injection Influenza Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injection Influenza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Injection Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Injection Influenza Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Injection Influenza Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injection Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Injection Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Injection Influenza Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Injection Influenza Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injection Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Injection Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Injection Influenza Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Injection Influenza Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Injection Influenza Vaccine Sales by Type (2018-2029)
4.1.1 Global Injection Influenza Vaccine Sales by Type (2018-2024)
4.1.2 Global Injection Influenza Vaccine Sales by Type (2024-2029)
4.1.3 Global Injection Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Injection Influenza Vaccine Revenue by Type (2018-2029)
4.2.1 Global Injection Influenza Vaccine Revenue by Type (2018-2024)
4.2.2 Global Injection Influenza Vaccine Revenue by Type (2024-2029)
4.2.3 Global Injection Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Injection Influenza Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Injection Influenza Vaccine Sales by Application (2018-2029)
5.1.1 Global Injection Influenza Vaccine Sales by Application (2018-2024)
5.1.2 Global Injection Influenza Vaccine Sales by Application (2024-2029)
5.1.3 Global Injection Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Injection Influenza Vaccine Revenue by Application (2018-2029)
5.2.1 Global Injection Influenza Vaccine Revenue by Application (2018-2024)
5.2.2 Global Injection Influenza Vaccine Revenue by Application (2024-2029)
5.2.3 Global Injection Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Injection Influenza Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Sanofi Injection Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 CSL Injection Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 GSK Injection Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Viatris Injection Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 AstraZeneca Injection Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Hualan Bio Injection Influenza Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Changchun Institute of Biological Injection Influenza Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Sinovac Injection Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 Jiangsu GDK
6.9.1 Jiangsu GDK Corporation Information
6.9.2 Jiangsu GDK Description and Business Overview
6.9.3 Jiangsu GDK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Jiangsu GDK Injection Influenza Vaccine Product Portfolio
6.9.5 Jiangsu GDK Recent Developments/Updates
6.10 KM Biologics
6.10.1 KM Biologics Corporation Information
6.10.2 KM Biologics Description and Business Overview
6.10.3 KM Biologics Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 KM Biologics Injection Influenza Vaccine Product Portfolio
6.10.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injection Influenza Vaccine Industry Chain Analysis
7.2 Injection Influenza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injection Influenza Vaccine Production Mode & Process
7.4 Injection Influenza Vaccine Sales and Marketing
7.4.1 Injection Influenza Vaccine Sales Channels
7.4.2 Injection Influenza Vaccine Distributors
7.5 Injection Influenza Vaccine Customers
8 Injection Influenza Vaccine Market Dynamics
8.1 Injection Influenza Vaccine Industry Trends
8.2 Injection Influenza Vaccine Market Drivers
8.3 Injection Influenza Vaccine Market Challenges
8.4 Injection Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Injection Influenza Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Injection Influenza Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Injection Influenza Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Injection Influenza Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Injection Influenza Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Injection Influenza Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Injection Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Injection Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Injection Influenza Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Injection Influenza Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injection Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Influenza Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injection Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Injection Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Injection Influenza Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Injection Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Injection Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Injection Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Injection Influenza Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Injection Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Injection Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Injection Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Injection Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Injection Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Injection Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Injection Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Injection Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Injection Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Injection Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Injection Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Injection Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Injection Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Injection Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Injection Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Injection Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Injection Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Injection Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Injection Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Injection Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Injection Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Injection Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Injection Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Injection Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Injection Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Injection Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Injection Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Injection Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Injection Influenza Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Injection Influenza Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Injection Influenza Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Injection Influenza Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Injection Influenza Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Injection Influenza Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Injection Influenza Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Injection Influenza Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Injection Influenza Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Injection Influenza Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Injection Influenza Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Injection Influenza Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Injection Influenza Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Injection Influenza Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Injection Influenza Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Sanofi Injection Influenza Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. CSL Injection Influenza Vaccine Product
Table 79. CSL Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. GSK Injection Influenza Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Viatris Corporation Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Viatris Injection Influenza Vaccine Product
Table 89. Viatris Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. AstraZeneca Injection Influenza Vaccine Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Hualan Bio Corporation Information
Table 96. Hualan Bio Description and Business Overview
Table 97. Hualan Bio Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Hualan Bio Injection Influenza Vaccine Product
Table 99. Hualan Bio Recent Developments/Updates
Table 100. Changchun Institute of Biological Corporation Information
Table 101. Changchun Institute of Biological Description and Business Overview
Table 102. Changchun Institute of Biological Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Changchun Institute of Biological Injection Influenza Vaccine Product
Table 104. Changchun Institute of Biological Recent Developments/Updates
Table 105. Sinovac Corporation Information
Table 106. Sinovac Description and Business Overview
Table 107. Sinovac Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Sinovac Injection Influenza Vaccine Product
Table 109. Sinovac Recent Developments/Updates
Table 110. Jiangsu GDK Corporation Information
Table 111. Jiangsu GDK Description and Business Overview
Table 112. Jiangsu GDK Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Jiangsu GDK Injection Influenza Vaccine Product
Table 114. Jiangsu GDK Recent Developments/Updates
Table 115. KM Biologics Corporation Information
Table 116. KM Biologics Description and Business Overview
Table 117. KM Biologics Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. KM Biologics Injection Influenza Vaccine Product
Table 119. KM Biologics Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Injection Influenza Vaccine Distributors List
Table 123. Injection Influenza Vaccine Customers List
Table 124. Injection Influenza Vaccine Market Trends
Table 125. Injection Influenza Vaccine Market Drivers
Table 126. Injection Influenza Vaccine Market Challenges
Table 127. Injection Influenza Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Injection Influenza Vaccine
Figure 2. Global Injection Influenza Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Injection Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Injection Influenza Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Injection Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. 6 Months to 3 Years
Figure 9. > 3 Years
Figure 10. Global Injection Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Injection Influenza Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Injection Influenza Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Injection Influenza Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Injection Influenza Vaccine Report Years Considered
Figure 15. Injection Influenza Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Injection Influenza Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Injection Influenza Vaccine Players: Market Share by Revenue in 2022
Figure 18. Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Injection Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Injection Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Injection Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. U.S. Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Injection Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Injection Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Injection Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Injection Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Taiwan Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Philippines Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Injection Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 44. Latin America Injection Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Injection Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Injection Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. U.A.E Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Injection Influenza Vaccine by Type (2018-2029)
Figure 54. Global Revenue Market Share of Injection Influenza Vaccine by Type (2018-2029)
Figure 55. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Injection Influenza Vaccine by Application (2018-2029)
Figure 57. Global Revenue Market Share of Injection Influenza Vaccine by Application (2018-2029)
Figure 58. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 59. Injection Influenza Vaccine Value Chain
Figure 60. Injection Influenza Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries